Alison DeDent

Dr. Alison DeDent is a Research Associate at the University of California, San Francisco (UCSF) School of Medicine. She practices in the UCSF Interstitial Lung Disease (ILD) Clinic, Zuckerberg San Francisco General (ZSFG) Medical ICU, UCSF Neuro ICU, and ZSFG Fellow's Chest Clinic. Her work focuses on geographic and socioeconomic health disparities in interstitial lung disease and telehealth interventions to improve care equity.

• Education:
  • MD - University of Toledo College of Medicine (2014)
  • BS - The Ohio State University in Biology (2009)
  • Clinical Fellowship - UCSF in Pulmonary and Critical Care Medicine (2020)
  • Residency - University of Colorado in Internal Medicine (2017)
  • MAS - UCSF in Clinical Research (2022)

Research Interests include health disparities, implementation science, and telehealth applications for vulnerable populations with idiopathic pulmonary fibrosis and interstitial lung disease. She leads funded studies like the American Thoracic Society Award in ILD (2023-2024), Nina Ireland Foundation virtual ILD team meeting project (2023-2025), and Pulmonary Fibrosis Foundation PFF Scholars telehealth intervention (2022-2024).

Scientific Awards:

• Alpha Omega Alpha Honor Medical Society - University of Toledo College of Medicine (2014)

Her publications highlight trends in health equity for rural and low-income populations, with recent work appearing in journals like Chest, Annals of the American Thoracic Society, and Thorax. Topics span telehealth, antifibrotic medication disparities, and environmental/social determinants in lung disease outcomes.